FDA awards Breakthrough Device Designation to Impella ECP On August 18, 2021, Abiomed received breakthrough device designation from the United States Food and Drug Administration (FDA) fo...
FDA's Green Flag to Ascendis's Once-Weekly SKYTROFA for Treatment of Pediatric Growth Hormone DeficiencyFor the treatment of growth failure due to deficiency of growth hormones, the USFDA appr...
Boston Scientific starts recruitment for randomized controlled trials for the EkoSonic™ Endovascular SystemOn August 04, 2021, Boston Scientific Corporation started the enrolment in the...
As per the WHO, “the number of people affected with Diabetes has grown significantly from 108 million in 1980 to 422 million in 2014. A rising trend in prevalence is observed in low- and middle-in...
Primary hyperoxaluria (PH) is a rare autosomal genetic form of Hyperoxaluria, a condition that leads to the excessive urinary excretion of oxalate. Till now, three distinct hereditary enzymatic de...
Nevro Received FDA Approval of its 10 kHz High-Frequency Spinal Cord Stimulation Therapy for Treatment of Chronic Pain Associated with Painful Diabetic NeuropathyOn July 19, 2021, Nevro Corp. ...
Dry Age-related Macular Degeneration (Dry AMD), also called atrophic AMD, is the most common form of.....
According to WHO, Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death g.....
Well, MDS being one of the rare blood cancers, has been into the limelight of researchers since a de.....
Chronic diseases (CDs) pose a significant challenge to healthcare in the 21st century. ...
Data and analytics today are playing a major role in the organization’s growth. Stakeho...
Onychomycosis is the most commonly prevalent nail infection in adults. It is a fungal i...
The necessity of a robust Angelman syndrome pipeline is indispensable at the current mo...
Neurological disorders are one of the major causes of death and disability across the g...
